You are here

Immune Design

Merck to buy immunotherapy developer Immune Design for $300 million

Merck to buy immunotherapy developer Immune Design for $300 million

Reuters

Flag link:

Immune Design buries its PhIII work on cancer, and investors hit the panic button

Immune Design buries its PhIII work on cancer, and investors hit the panic button

Endpoints

Flag link:

Immune Design Poised on Progress of Pipeline Candidates

Immune Design Poised on Progress of Pipeline Candidates

Yahoo/Zacks.com

soft tissue sarcoma

Flag link:

Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma

Immune Design and Merck to Collaborate on Combination Trials of Two Immune Design Immunotherapies With Merck's KEYTRUDA for Non-Hodgkin's Lymphoma and Melanoma

Yahoo

clinical trials

non-Hodgkin's lymphoma

Flag link:

7 Biotech Stocks Moving Off The UBS Healthcare Conference

7 Biotech Stocks Moving Off The UBS Healthcare Conference

Yahoo/Benzinga

Cerulean Pharma

Endo International

Esperion Therapeutics

Flag link:

Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy

Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy

Yahoo

herpes simplex virus

Flag link:

Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy

Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy

Yahoo

GLAAS plantform

Flag link:

Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships

Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships

Seeking Alpha

Teva Pharmaceuticals

Pacific Biosciences

Baxter International

Amicus Therapeutics

Flag link: